Marimed Stock Today
| MRMD Stock | USD 0.15 0.01 6.25% |
Performance0 of 100
| Odds Of DistressLess than 50
|
Marimed is trading at 0.15 as of the 26th of November 2024, a 6.25 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.15. Marimed has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Marimed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 339.35 M outstanding shares. More on Marimed
Moving together with Marimed OTC Stock
Moving against Marimed OTC Stock
Follow Valuation Daily Balance Of Power
Check how we calculate scores
Marimed OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Marimed [MRMD] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 147.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Marimed's market, we take the total number of its shares issued and multiply it by Marimed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Marimed conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 339.35 M outstanding shares.
Marimed currently holds about 8.44 M in cash with 35.85 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Marimed Probability Of Bankruptcy
Ownership AllocationMarimed maintains a total of 339.35 Million outstanding shares. Marimed secures 17.9 % of its outstanding shares held by insiders and 0.81 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Marimed Ownership Details
Marimed Risk Profiles
| Mean Deviation | 3.4 | |||
| Standard Deviation | 5.37 | |||
| Variance | 28.86 | |||
| Risk Adjusted Performance | (0.05) |
Marimed Stock Against Markets
Picking the right benchmark for Marimed otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Marimed otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Marimed is critical whether you are bullish or bearish towards Marimed at a given time. Please also check how Marimed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Marimed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Marimed Corporate Management
Elected by the shareholders, the Marimed's board of directors comprises two types of representatives: Marimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marimed. The board's role is to monitor Marimed's management team and ensure that shareholders' interests are well served. Marimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Shaw | Chief Officer | Profile | |
| Steve West | VP Relations | Profile | |
| Howard Schacter | Chief Officer | Profile | |
| Sara Gullickson | VP Marketing | Profile | |
| Susan CPA | Chief Officer | Profile | |
| Jon Levine | President, CoFounder | Profile | |
| Charles Finnie | Chief Officer | Profile |
Other Information on Investing in Marimed OTC Stock
Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.